Navigation Links
The Catalyst Foundation's Groundbreaking ACE Study-Based Services Bring Transformational Change to Healthcare
Date:2/26/2009

LANCASTER, Calif., Feb. 26 /PRNewswire-USNewswire/ -- Heart disease, stroke, cancer, and diabetes are among the leading causes of death in America. These conditions cause extreme human suffering, and place an enormous financial burden on patients and their families as well as on our severely overextended health care system.

The landmark Adverse Childhood Experiences (ACE) Study, an ongoing collaboration between the Centers for Disease Control and Kaiser Permanente, provides firm scientific evidence that childhood abuse and trauma is the underlying cause of these and other serious medical conditions. Catalyst's Bartz-Altadonna Memorial Clinic's new system of primary medical care, based on the concepts of the ACE Study, helps patients address the root causes of their poor health: difficult childhood experiences which continue to influence their lives today. Catalyst is one of the only clinics in the world which utilizes the ACE Study findings to inform its system of primary medical care.

This state-of-the-art, evidence-based, compassionate, and patient-centered healthcare is available to all adults, especially the low-income, uninsured, and homeless. At Catalyst, childhood abuse and trauma is viewed as just another part of the human experience, one which can be discussed, worked through, and recovered from so that it no longer negatively affects our lives and health. A variety of ancillary healing modalities are offered by Catalyst for this purpose, including meditation, writing, art, yoga, martial arts, psychotherapy from a trauma theory model, and health education programs on the effects of trauma on individuals and society. No patient is turned away for lack of ability to pay.

Many adults traumatized as children have serious psychosocial issues resulting in poverty and homelessness. Catalyst helps our patients with basic needs, including food, housing, and transportation. For many such individuals, pets are a critically important lifeline; through our partnership with VCA West LA Animal Hospital, our patients' pets receive free food and veterinary care.

Catalyst will hold a press conference to announce its pioneering new programs during its Open House festivities at 11:00 am on Tuesday, March 3, 2009. Activities include tours of the expanded Catalyst facility, a ribbon-cutting by the Chamber of Commerce, and a special raffle of "Barry," a two-foot high solid chocolate rooster from our community partner, the Lemon Leaf Cafe.

Info: www.acestudy.org; http://www.cdc.gov/nccdphp/ACE/; www.thecatalyst-foundation.org; www.creatingahealingsociety.org

    Terry Marks
    The Catalyst Foundation
    44758 Elm Avenue
    Lancaster, CA
    RSVP: (310) 890-6059 or tmarksconsulting@charter.net


'/>"/>
SOURCE The Catalyst Foundation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Upcoming Packard/Stanford Autism Symposium a Catalyst for Collaboration among Researchers and Community
2. Catalyst Biosciences Appoints Dr. Todd Lorenz Chief Medical Officer
3. Catalyst mystery unlocked
4. CATalyst Council Forms to Address Feline Health Care
5. Congress Approves ePrescribing Initiative in Medicare Reform Bill: Critical Catalyst in Driving a New Generation of Prescribing
6. Catalyst Pharmaceutical Partners, Inc. Set to Join Russell Microcap(R) Index
7. Case in Point: Patient Control of Data Critical Catalyst for Online Health Care Revolution
8. Catalyst Pharmaceutical Partners, Inc. Names Director - Corporate Clinical Compliance
9. Cardiva Medical, Inc. to Present Highlights of the Boomerang Catalyst(TM) II System at the Investment in Innovation (In3) West Conference on February 29, 2008 in Las Vegas, NV
10. CATalyst Summit Declared a Success: Its All About the Cat!
11. Catalyst Pharmaceutical Partners Announces Positive Phase II Trial Results for Vigabatrin in the Treatment of Cocaine Addiction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... January 19, 2017 , ... ... offering treatments for patients with sleep apnea and TMJ disorders. These conditions are ... physical health. Dr. Rassouli provides personalized care to reduce the risk of these ...
(Date:1/19/2017)... ... ... Sam & Associates Insurance Agency, a full service firm providing asset protection ... Area, is launching a charity drive to raise awareness of heart disease risk factors ... killer of adult men and women in America, and is responsible for over 25% ...
(Date:1/19/2017)... Madison, Mississippi (PRWEB) , ... January 19, 2017 , ... ... its Siena Center. , Siena Center is a skilled nursing facility on the grounds ... private and semiprivate rooms. It recently was voted the best nursing home in Mississippi ...
(Date:1/19/2017)... ... January 18, 2017 , ... The CHP suggests that California drivers can avoid ... slowing down and increasing the space between themselves and other vehicles, according to a ... attorney Raymond R. Hassanlou notes that, rain or shine, drivers should always incorporate safe ...
(Date:1/19/2017)... ... January 19, 2017 , ... Sales Focus Inc. (SFI), ... into the US market. , Over the past 20 years SFI has been recognized ... SFI has launched six new clients into the US market. The new clients ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... URBANDALE, Iowa , Jan. 18, 2017 /PRNewswire/ ... announced that subsidiary Caretta Therapeutics plans, in the ... product. Venodol, a topical roll-on intended to provide ... to opioid and steroidal analgesics. It was developed ... Reid to commercialize products derived from snake ...
(Date:1/18/2017)... , Jan. 18, 2017  Kratom leaves, from ... family, are often used to prepare tea-like beverages ... several million Americans annually to increase alertness, enhance ... remedy for minor aches and pains. PinneyAssociates, review ... intended to assist FDA and DEA in determining ...
(Date:1/18/2017)... 18, 2017  Dermata Therapeutics, LLC, a biotechnology ... a variety of dermatological diseases, announces dosing the ... a Phase 2 acne rosacea study. DMT210 is ... proinflammatory cytokines in the skin responsible for the ... This clinical trial, DMT210-003, is a ...
Breaking Medicine Technology: